Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products

BACKGROUND: The use of pharmacokinetic (PK) studies to help design personalized prophylaxis regimens for factor VIII (FVIII) concentrate in individuals with hemophilia A has been recognized for many years but only became practical for routine clinical use with the availability of web-accessible population PK applications based on Bayesian analysis. OBJECTIVE: To compare PK variables using population PK studies done on 2 extended half-life …